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On the 23rd of  January 2011, we admitted a 46-year-old 
man to Queen Elizabeth Central Hospital (QECH) with a 
5-month history of  recurrent vomiting. This was associated 
with nausea. He would vomit at least 5 times per day. The 
vomitus was non-projectile, would usually take the colour of  
the food eaten and was never bilious. There was no history 
of  abdominal pain, dysphagia, fever or headache. The colour 
of  stools was normal but he had complained of  constipation 
for 6 days prior to admission. He also admitted to weight 
loss, which could not be quantified.
Prior to attending QECH he had been seen in several health 
facilities and had been treated with promethazine, but had had 
no relief  of  his symptoms. An endoscopy done at another 
hospital was documented as follows: ‘endoscopy shows reflux 
oesophagitis and lax lower oesophageal sphincter’ There was 
no comment on whether there were structural abnormalities 
at the level of  the pylorus or duodenum.
He had been diagnosed with type 2 diabetes mellitus in 
December 2010 on the basis of  high random blood glucose 
readings.  He had been prescribed glibenclamide but stopped 
as he felt it was making him vomit more, and was now only 
taking metformin. Blood glucose measurements since the 
start of  treatment were not available so we do not know how 
well the diabetes had been controlled.
He had a history of  moderate alcohol consumption (< 20 
units per week) but had not taken alcohol since the symptoms 
started. He had no history of  smoking. He was HIV negative. 
He used to work as a foreman for a construction company 
but had stopped work owing to the severity of  his symptoms. 
He was married with 3 children. There was no family history 
of  diabetes.
On examination, he was moderately cachexic and dehydrated. 
His blood pressure (BP) was 130/80 mmHg, temperature 
37oC, pulse 92/minute, respiratory rate 28/minute. His 
conjunctivae were pink, there were no oral lesions and he 
had no lymphadenopathy, including Virchow’s node. Chest 
examination was normal. Abdominal examination was 
normal except there were hard stools in the rectum. His 
fundoscopy showed dot and blot haemorrhages, consistent 
with background diabetic retinopathy.
His random blood glucose concentration was 252mg/dl and 
there were no ketones in his urine. Blood potassium and 
sodium were 3.1 mmol/L (3.6 – 5.0) and 127 mmol/L (135 
– 145) respectively. He had a normal blood creatinine and no 
proteinuria.
Questions
1) What is the differential diagnosis of his vomiting? 
2) What further investigations are indicated for the 
vomiting? 
3) What further assessments are indicated for his 
diabetes?
Discussion
1) Causes of  vomiting can be divided into gastrointestinal 
causes, central causes and metabolic causes. In this case 
the causes of  vomiting that should be considered include 
gastrointestinal causes such as achalasia, gastric malignancy, 
pyloric stenosis, gastric or duodenal ulcer, gastroparesis and 
generalized motility disorders such as intestinal myopathies 
and neuropathies. Central causes include migraine, cyclical 
vomiting, psychogenic vomiting, space occupying lesions and 
labyrinthitis. Metabolic causes such as drugs, hypercalcaemia 
and hyponatraemia should also be considered.
2)A careful history and examination are crucial for obtaining 
a diagnosis. Tests should include bloods tests: urea, sodium 
and potassium to look for evidence of  electrolyte imbalance 
- either causing vomiting or a consequence of  the vomiting - 
and a full blood count to look for a microcytic anaemia related 
to possible gastrointestinal blood loss. Ideally a serum calcium 
level would also be performed to exclude hypercalcaemia. An 
abdominal X-ray is important to exclude small bowel or large 
bowel obstruction. Endoscopy is preferable to barium meal 
in investigating the stomach as it enables more pathology 
to be seen and biopsies to be taken. Where available final 
investigations would be scintigraphy, (described below) to 
look for evidence of  delayed gastric emptying, and CT of  
the brain to exclude space-occupying lesions.
An endoscopy was repeated and the findings were of  a 
normal oesophagusand a long tubular stomach with normal 
mucosal appearance. There was no food residue seen. The 
duodenum was normal to the second part. The endoscopy 
showed no evidence of  obstruction to that level.
3) Further assessment of  his diabetes should focus on 
screening for complications of  diabetes. Although he had 
only been diagnosed with diabetes one month previously 
it is not uncommon for type 2 diabetics to have evidence 
of  complications at the time of  presentation. The finding 
of  background retinopathy (a microvascular complication) 
implies duration of  undiagnosed diabetes of  at least 5 
years in our patient. Significant nephropathy was unlikely 
with the absence of  proteinuria although a dipstick test for 
microalbuminuria or a urine albumin/creatinine ratio would 
have been more sensitive screening tests for nephropathy. A 
glycosylated haemoglobin level (HbA1C), if  available, would 
have been a useful indication of  his glycaemic control.
On further inquiry, he admitted to having numb feet, erectile 
impotence and dizziness on standing. Monofilament sensory 
testing revealed sensory loss in both feet. He had marked 
postural hypotension with a lying BP of  160/100mmHg and 
standing BP of  120/80mmHg. This finding, together with 
the erectile impotence, was highly suggestive of  diabetic 
sensory and autonomic neuropathy. Because we suspected 
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autonomic neuropathy we went on to carry out an autonomic 
function test using an ECG strip to demonstrate loss of  
respiratory sinusarrthymia. If  there is autonomic neuropathy 
the distance between R waves remains constant throughout 
the respiratory cycle. This was seen clearly in our patient, 
even on deep breathing (see figure 1 below).
Figure 1: Lead I ECG of  J.C. demonstrating loss of  respiratory 
sinus rhythm as shown by constant R-R intervals in inspiration and 
expiration.
The combination of  typical, intractable symptoms of  
vomiting, with a normal endoscopy and the presence of  
diabetic complications, including autonomic neuropathy, 
makes diabetic gastroparesis the most likely diagnosis.
Gastroparesis is the symptomatic delay in gastric emptying 
of  solid or liquid meals secondary to impaired gastric motility 
in the absence of  a mechanical obstruction. The common 
symptoms of  gastroparesis include vomiting, nausea 
and bloating. There may also be constipation. Diabetes is 
implicated in the majority of  cases of  gastroparesis. Other 
causes include gastric surgery and neurological diseases 
e.g. multiple sclerosis, brainstem tumour/cerebral vascular 
accident, stress and Parkinson’s disease1,2and rheumatologic 
disorders e.g. in systemic sclerosis (scleroderma)3. Many 
cases are idiopathic4. In fact, in one highly referenced study 
by Soykan et al published in 1998 in the Digestive Diseases 
and Sciences journal, no specific cause could be identified 
in approximately one-half  of  patients with delayed gastric 
emptying in various reports.4
Diabetic gastroparesis may occur in people with type 1 or 
2 diabetes. Studies, mostly surveys, among Caucasians with 
diabetes showed that 5 – 12% of  patients had symptoms that 
were attributable to gastroparesis.5,6,7,8 There are no published 
data on the prevalence of  gastroparesis among black patients 
with diabetes. Patients with diabetes in whom gastroparesis 
develops have often had diabetes for at least 5 years and 
typically have retinopathy, neuropathy, and nephropathy. 
Diabetic autonomic neuropathy may also lead to erectile 
dysfunction. This may occur in the absence of  other signs 
of  diabetic autonomic neuropathy and may be the clue that 
indicates that autonomic neuropathy is present. It should be 
remembered, however, that commonly used antihypertensive 
drugs, such as thiazide diuretics and β blockers, can also cause 
impotence. The mechanism of  gastroparesis is thought to be 
neuropathy affecting the vagus nerve, with reduction in the 
numbers of  inhibitory neurons that are important for motor 
coordination and the number of  pacemaker cells (interstitial 
cells of  Cajal).9
Diabetic gastroparesis may result in nutritional compromise, 
and impaired glucose control. The quality of  life invariably 
becomes poor and such patients become frequent attendees 
at hospital.
Diagnostic testing
In cases of  suspected diabetic gastroparesis, gastric 
outflow obstruction should first be ruled out with the 
use of  esophagogastroduodenoscopy or a barium study 
of  the stomach. Food retained in the stomach after a 12-
hour fast is suggestive of  gastroparesis. Measurement of  
gastric emptying of  digestible solids is the mainstay of  the 
diagnosis of  gastroparesis. Scintiscanning using a nuclear 
labelled meal and measuring gastric emptying using a gamma 
camera at 15-minute intervals for 4 hours after food intake is 
considered the gold standard for measuring gastric emptying 
in detail. However, a simplified approach involving hourly 
scans to quantify residual gastric content is often used in 
practice; retention of  over 10% of  the meal after 4 hours is 
abnormal.
Management
Key principles in the management of  diabetic gastroparesis are 
the correction of  exacerbating factors, including optimization 
of  glucose and electrolyte levels, the provision of  nutritional 
support, the use of  prokinetic and symptomatic therapies 
and counselling. Improved glycaemic control is important 
as in some cases the neuropathy and gastric function may 
improve. It is advisable that these patients take small, more 
frequent meals that are easier to digest, especially liquids and 
food low in fat and fibrecontent. These have been shown 
to minimize symptoms of  gastroparesis. Metoclopramide, 
domperidone and erythromycin are the commonest prokinetic 
drugs used in gastroparesis. Erythromycin interacts with the 
motilin receptor and may promote gastric emptying. Studies 
have shown these agents to increase gastric emptying by 
25 to 75% and reduce the severity of  symptoms by 25 to 
68%.10,11,12 When pain relief  is required, tramadol and 
opiates should be avoided. These have inhibiting effects 
on motility. Nonsteroidal agents should also be avoided as 
these have the potential for renal damage in patients with 
diabetes.
Outcome and recommendation
In this patient control of  the vomiting was difficult but 
eventually he responded to domperidone 10 mg tds and was 
discharged. Perhaps predictably, he presented again after 
only 2 weeks when he ran out of  domperidone.
This case represents a typical example of  diabetic 
gastroparesis. It is likely that there are many diabetic patients 
who have this problem and the diagnosis is being missed. 
The case serves to remind us to always consider diabetic 
gastroparesis as a differential diagnosis in diabetic patients 
who present with chronic gastrointestinal symptoms.
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